bf/NASDAQ:ANIK_icon.jpeg

NASDAQ:ANIK

Anika Therapeutics, Inc.

  • Stock

USD

Last Close

25.50

17/05 20:00

Market Cap

357.24M

Beta: 0.83

Volume Today

39.18K

Avg: 81.01K

PE Ratio

−14.02

PFCF: −31.16

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
9.64M
-
11.70M
21.39%
13.67M
16.84%
15.46M
13.08%
19.01M
22.95%
21.67M
13.99%
21.65M
0.09%
34.10M
57.53%
41.11M
20.55%
37.89M
7.84%
43.08M
13.69%
average payables
2.57M
-
2.00M
22.21%
4.75M
137.87%
5.30M
11.59%
4.53M
14.66%
4.95M
9.28%
3.49M
29.47%
6.41M
83.74%
8.31M
29.66%
8.35M
0.54%
9.47M
13.33%
average receivables
20.10M
-
17.94M
10.72%
19.40M
8.12%
24.63M
26.92%
25.71M
4.41%
22.30M
13.27%
21.93M
1.67%
23.59M
7.59%
26.97M
14.34%
32.23M
19.51%
35.29M
9.49%
book value per share
9.63
-
12.13
26.02%
14.12
16.36%
15.17
7.47%
18.08
19.15%
18.25
0.97%
20.42
11.88%
19.15
6.21%
19.94
4.08%
19.61
1.62%
14.48
26.15%
capex per share
-0.03
-
-0.11
238.03%
-0.62
483.87%
-0.95
54.52%
-0.62
35.45%
-0.32
47.67%
-0.20
37.90%
-0.11
42.82%
-0.36
211.98%
-0.51
43.96%
-0.37
27.97%
capex to depreciation
-0.09
-
-0.33
257.23%
-2.44
640.48%
-3.75
53.58%
-2.09
44.23%
-0.79
62.36%
-0.47
40.10%
-0.12
74.38%
-0.36
197.09%
-0.52
43.85%
-0.38
26.22%
capex to operating cash flow
-0.02
-
-0.04
121.71%
-0.24
507.95%
-0.59
149.33%
-0.22
62.63%
-0.13
39.40%
-0.08
42.71%
-0.12
63.11%
-0.61
391.53%
-1.70
177.22%
3.04
278.77%
capex to revenue
-0.01
-
-0.01
150.44%
-0.10
574.50%
-0.14
36.66%
-0.08
41.59%
-0.04
44.29%
-0.02
44.08%
-0.01
49.41%
-0.03
178.85%
-0.05
37.69%
-0.03
32.04%
cash per share
4.50
-
7.28
62.00%
9.27
27.30%
8.50
8.35%
10.79
26.97%
11.01
2.05%
13.10
18.95%
6.91
47.22%
6.55
5.19%
5.93
9.54%
4.97
16.14%
days of inventory on hand
176.31
-
216.36
22.71%
258.98
19.70%
242.80
6.25%
293.92
21.05%
248.55
15.44%
279.27
12.36%
274.56
1.69%
202.67
26.18%
231.63
14.29%
266.32
14.97%
days payables outstanding
44.80
-
20.95
53.24%
143.93
587.10%
34.99
75.69%
90.00
157.24%
36.68
59.25%
48.65
32.66%
53.38
9.71%
42.96
19.52%
52.86
23.04%
56.61
7.10%
days sales outstanding
91.09
-
59.29
34.91%
84.98
43.33%
97.44
14.66%
76.67
21.31%
71.84
6.30%
73.50
2.31%
67.43
8.25%
73.70
9.29%
80.90
9.76%
78.76
2.64%
debt to assets
-0.00
-
-0.00
28.63%
0.07
-
0.06
9.72%
0.06
1.87%
0.09
46.75%
0.11
21.27%
debt to equity
-0.00
-
-0.00
31.17%
0.08
-
0.08
5.66%
0.07
11.49%
0.11
48.20%
0.14
26.46%
dividend yield
earnings yield
0.04
-
0.06
67.42%
0.05
15.77%
0.05
16.11%
0.04
10.57%
0.04
4.74%
0.04
3.71%
-0.04
200.32%
0.01
121.50%
-0.03
530.30%
-0.25
622.02%
enterprise value
474.22M
-
497.84M
4.98%
459.17M
7.77%
614.57M
33.84%
652.48M
6.17%
396.35M
39.25%
596.08M
50.39%
568.75M
4.58%
440.84M
22.49%
375.57M
14.81%
288.27M
23.24%
enterprise value over ebitda
14.80
-
8.10
45.27%
9.54
17.74%
12.14
27.30%
14.27
17.49%
18.22
27.72%
17.40
4.50%
-926.30
5,422.12%
-11.14
98.80%
-19.36
73.79%
-25.70
32.78%
ev to operating cash flow
18.84
-
12.45
33.92%
11.75
5.61%
25.82
119.67%
15.99
38.08%
11.35
29.00%
16.11
41.91%
43.53
170.25%
52.50
20.60%
85.18
62.25%
-161.23
289.27%
ev to sales
6.32
-
4.71
25.36%
4.94
4.73%
5.94
20.40%
5.75
3.23%
3.75
34.73%
5.20
38.51%
4.36
16.18%
2.98
31.58%
2.40
19.41%
1.73
28.04%
free cash flow per share
1.76
-
2.62
49.16%
2.00
23.68%
0.67
66.64%
2.18
227.64%
2.10
4.06%
2.42
15.51%
0.80
66.77%
0.23
71.90%
-0.21
193.52%
-0.49
132.96%
free cash flow yield
0.05
-
0.06
39.71%
0.05
18.52%
0.01
74.00%
0.04
197.55%
0.06
53.89%
0.05
25.13%
0.02
61.94%
0.01
64.51%
-0.01
213.21%
-0.02
204.31%
graham net net
4.44
-
7.50
69.09%
9.19
22.57%
9.26
0.76%
11.46
23.73%
11.76
2.64%
12.10
2.91%
3.26
73.11%
5.16
58.55%
4.71
8.70%
4.41
6.37%
graham number
17.79
-
26.70
50.08%
25.58
4.19%
27.51
7.55%
29.80
8.32%
23.07
22.57%
29.75
28.92%
26.96
9.38%
11.35
57.91%
21.22
87.01%
42.87
102.04%
income quality
1.22
-
1.04
14.70%
1.27
21.73%
0.73
42.42%
1.28
75.41%
1.87
45.40%
1.36
27.04%
-0.54
140.03%
2.03
472.85%
-0.30
114.61%
0.02
107.29%
intangibles to total assets
0.18
-
0.12
34.30%
0.08
32.22%
0.07
10.57%
0.07
8.11%
0.06
8.43%
0.05
24.37%
0.27
489.48%
0.26
4.74%
0.23
9.54%
0.03
88.08%
interest coverage
-73.03
-
-1.06K
1,347.31%
-401.12
62.05%
-192.42
52.03%
-96.68
49.76%
-14.92
84.57%
47.91
-
98.30
105.18%
-29.66
130.18%
-11.01
62.89%
interest debt per share
-0.03
-
-0.00
87.50%
-0.01
214.45%
-0.02
70.07%
-0.03
53.21%
-0.10
211.08%
1.59
1,678.85%
1.56
2.24%
1.44
7.46%
2.17
50.23%
2.14
1.26%
inventory turnover
2.07
-
1.69
18.51%
1.41
16.46%
1.50
6.66%
1.24
17.39%
1.47
18.26%
1.31
11.00%
1.33
1.72%
1.80
35.47%
1.58
12.50%
1.37
13.02%
invested capital
-0.00
-
-0.00
31.17%
0.08
-
0.08
5.66%
0.07
11.49%
0.11
48.20%
0.14
26.46%
market cap
537.56M
-
597.99M
11.24%
569.88M
4.70%
718.83M
26.14%
785.74M
9.31%
485.40M
38.22%
732.17M
50.84%
643.69M
12.09%
515.99M
19.84%
431.01M
16.47%
332.10M
22.95%
net current asset value
74.18M
-
123.13M
65.97%
151.53M
23.07%
152.97M
0.95%
187.20M
22.38%
187.56M
0.19%
193.41M
3.12%
84.18M
56.48%
108.08M
28.39%
105.98M
1.94%
104.94M
0.98%
net debt to ebitda
-1.98
-
-1.63
17.56%
-2.30
41.11%
-2.06
10.42%
-2.91
41.44%
-4.09
40.49%
-3.97
2.94%
122.05
3,171.31%
1.90
98.44%
2.86
50.49%
3.91
36.76%
net income per share
1.46
-
2.61
78.74%
2.06
21.11%
2.22
7.63%
2.18
1.53%
1.30
40.61%
1.93
48.55%
-1.69
187.57%
0.29
117.02%
-1.02
455.48%
-5.64
452.74%
operating cash flow per share
1.79
-
2.72
52.46%
2.62
3.96%
1.62
38.03%
2.80
72.73%
2.42
13.65%
2.62
8.39%
0.92
64.94%
0.58
36.53%
0.30
48.07%
-0.12
140.29%
payables turnover
8.15
-
17.42
113.84%
2.54
85.45%
10.43
311.41%
4.06
61.13%
9.95
145.39%
7.50
24.62%
6.84
8.85%
8.50
24.25%
6.91
18.72%
6.45
6.63%
receivables turnover
4.01
-
6.16
53.64%
4.30
30.23%
3.75
12.79%
4.76
27.09%
5.08
6.73%
4.97
2.26%
5.41
9.00%
4.95
8.50%
4.51
8.89%
4.63
2.72%
research and ddevelopement to revenue
0.09
-
0.08
17.98%
0.10
25.29%
0.10
7.43%
0.17
59.56%
0.17
4.04%
0.15
15.62%
0.18
23.52%
0.18
2.95%
0.18
2.44%
0.20
8.74%
return on tangible assets
0.16
-
0.22
39.17%
0.14
36.72%
0.15
2.87%
0.12
17.43%
0.07
40.75%
0.09
20.62%
-0.09
204.57%
0.02
117.82%
-0.06
446.23%
-0.31
465.08%
revenue per share
5.33
-
7.19
34.98%
6.23
13.44%
7.04
13.07%
7.78
10.52%
7.31
6.08%
8.12
11.05%
9.17
13.02%
10.26
11.88%
10.73
4.55%
11.37
5.98%
roe
0.15
-
0.22
41.84%
0.15
32.20%
0.15
0.15%
0.12
17.35%
0.07
41.18%
0.09
32.77%
-0.09
193.36%
0.01
116.36%
-0.05
461.35%
-0.39
648.46%
roic
0.15
-
0.21
41.15%
0.15
32.28%
0.15
0.13%
0.12
17.79%
0.07
44.31%
0.08
16.59%
-0.04
149.47%
-0.10
150.53%
-0.04
53.69%
-0.09
106.41%
sales general and administrative to revenue
0.17
-
0.14
17.15%
0.16
11.67%
0.17
9.30%
0.19
8.99%
0.33
71.28%
shareholders equity per share
9.63
-
12.13
26.02%
14.12
16.36%
15.17
7.47%
18.08
19.15%
18.25
0.97%
20.42
11.88%
19.15
6.21%
19.94
4.08%
19.61
1.62%
14.48
26.15%
stock based compensation to revenue
0.02
-
0.02
9.87%
0.02
57.17%
0.03
37.14%
0.05
56.04%
0.10
104.39%
0.05
49.25%
0.04
22.26%
0.08
81.67%
0.09
22.16%
0.09
0.18%
tangible asset value
107.19M
-
154.86M
44.47%
191.71M
23.79%
205.33M
7.11%
244.64M
19.14%
246.57M
0.79%
273.10M
10.76%
172.83M
36.72%
196.92M
13.94%
203.63M
3.40%
204.69M
0.52%
tangible book value per share
7.61
-
10.55
38.65%
12.84
21.67%
13.99
8.94%
16.78
20.02%
17.07
1.72%
19.34
13.28%
12.15
37.16%
13.67
12.52%
13.98
2.27%
13.65
2.38%
working capital
85.31M
-
133.05M
55.96%
159.16M
19.62%
161.64M
1.56%
193.25M
19.56%
191.65M
0.83%
219.47M
14.51%
140.52M
35.97%
138.73M
1.27%
141.63M
2.09%
132.25M
6.62%

All numbers in USD (except ratios and percentages)